613 related articles for article (PubMed ID: 11054288)
1. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
[TBL] [Abstract][Full Text] [Related]
2. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
[TBL] [Abstract][Full Text] [Related]
3. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
4. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
Daly TJ; Doten RC; Rusche JR; Auer M
J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
[TBL] [Abstract][Full Text] [Related]
5. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
6. Retention of conformational flexibility in HIV-1 Rev-RNA complexes.
Wilkinson TA; Zhu L; Hu W; Chen Y
Biochemistry; 2004 Dec; 43(51):16153-60. PubMed ID: 15610009
[TBL] [Abstract][Full Text] [Related]
7. Interaction of HIV Rev peptides with the Rev response element RNA.
Williamson JR; Battiste JL; Mao H; Frankel AD
Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
[TBL] [Abstract][Full Text] [Related]
8. Water, shape recognition, salt bridges, and cation-pi interactions differentiate peptide recognition of the HIV rev-responsive element.
Michael LA; Chenault JA; Miller BR; Knolhoff AM; Nagan MC
J Mol Biol; 2009 Sep; 392(3):774-86. PubMed ID: 19631217
[TBL] [Abstract][Full Text] [Related]
9. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
Charpentier B; Stutz F; Rosbash M
J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
[TBL] [Abstract][Full Text] [Related]
10. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
Luedtke NW; Liu Q; Tor Y
Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
[TBL] [Abstract][Full Text] [Related]
11. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
Sugaya M; Nishino N; Katoh A; Harada K
J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
[TBL] [Abstract][Full Text] [Related]
12. Structural dynamics of HIV-1 Rev and its complexes with RRE and 5S RNA.
Lam WC; Seifert JM; Amberger F; Graf C; Auer M; Millar DP
Biochemistry; 1998 Feb; 37(7):1800-9. PubMed ID: 9485305
[TBL] [Abstract][Full Text] [Related]
13. Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.
Peterson RD; Feigon J
J Mol Biol; 1996 Dec; 264(5):863-77. PubMed ID: 9000617
[TBL] [Abstract][Full Text] [Related]
14. Interactions between HIV Rev and nuclear import and export factors: the Rev nuclear localisation signal mediates specific binding to human importin-beta.
Henderson BR; Percipalle P
J Mol Biol; 1997 Dec; 274(5):693-707. PubMed ID: 9405152
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
Campbell LH; Borg KT; Arrigo SJ
Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
Luedtke NW; Tor Y
Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
[TBL] [Abstract][Full Text] [Related]
17. Solid-state NMR data support a helix-loop-helix structural model for the N-terminal half of HIV-1 Rev in fibrillar form.
Blanco FJ; Hess S; Pannell LK; Rizzo NW; Tycko R
J Mol Biol; 2001 Nov; 313(4):845-59. PubMed ID: 11697908
[TBL] [Abstract][Full Text] [Related]
18. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
Modem S; Reddy TR
J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
[TBL] [Abstract][Full Text] [Related]
19. Binding kinetics and bioassay of RRE mRNA fragments to a peptide containing the recognition domain of HIV-1 Rev.
West ML; Ramsdale TE
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):85-8. PubMed ID: 9575345
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
